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Exposure to pesticides, dyes, and pollutants that mimic the growth promoting effects of estrogen
may cause breast cancer. The pesticide DDT and the food colorant Red No. 3 were found to
increase the growth of HTB 133 but not estrogen receptor (ER) negative human breast cells (HTB
125) or rat liver epithelial cells (RLE). Red No. 3, fVestradiol, and DDT increase ER site-specific
DNA binding to the estrogen response element in HTB 133 cells and increase cyclin-dependent
kinase 2 activity in MCF-7 breast cancer cells. Site-specific DNA binding by p53 in RLE, HTB 125,
HTB 133, and MCF-7 cells was increased when they were treated with Red No. 3, which
suggests that cellular DNA was damaged by this colorant. Red No. 3 increased binding of the ER
from MCF-7 cells to the estrogen-responsive element. Consumption of Red No. 3, which has
estrogenlike growth stimulatory properties and may be genotoxic, could be a significant risk
factor in human breast carcinogenesis. Environ Health Perspect 105(Suppl 3):625-632 (1997)
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In the United States, breast cancer is the
most commonly diagnosed cancer and the
second leading cause ofcancer deaths (1).
It has been estimated that one in eight U.S.
women will develop breast cancer (2).
Further, the incidence ofbreast cancer in the
United States is increasing 1% per year in
the 1990s (2). The personal and economic
impacts ofbreast cancer make this disease a
serious national health care concern. The
total cost ofbreast cancer burdens the U.S.
economywith direct and productivity losses
ofapproximately $3.8 billion peryear (3).
Great progress has been made recently
in determining the molecular basis offamil-
ial forms ofbreast cancers (4). However,
only 5 to 15% of the total number of
breast cancers can be traced to an inherited
familial defect (4). Although the etiology
ofthe majority of breast cancers remains
undetermined, epidemiologic studies have
indicated that a dietary component con-
tributes to the risk ofdeveloping the dis-
ease (5,6). High-fat diets may be a risk
factor for breast cancer (5,6). However,
the focus on fat as a major risk factor has
shifted to the effects of hormones and
hormone-mimicking chemicals (2).
Compounds that mimic the effects of
estrogen are popularly referred to as xeno-
estrogens or environmental estrogens (7,8).
Pesticides such as DDT, dyes (phenol red),
and polychlorinated biphenyls are estro-
genic (9-11). It has been suggested that
exposure to xenoestrogens increases the risk
ofbreast cancer for women in industrial-
ized countries (8,14). However, the role of
DDT and other environmental estrogens
in the etiology ofbreast cancer in humans
is controversial (7,12-14).
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Recently, it has been shown that
phthalate plasticizers from plastic food-
packaging materials exhibit estrogenic
activity (15). Butylated hydroxyanisole, a
commonly used food preservative, also has
weak estrogenic effects (15). Phenosulfo-
thiazine, a red dye used in tissue culture
media as a pH indicator, is aweak estrogen
that stimulates the growth ofhuman breast
cells and binds to the estrogen receptor
(ER) in MCF-7 human breast cancer cells
(9). Because some food dyes are carcino-
gens (e.g., Red No. 4), we hypothesized
that the dietary component that increases
the risk of breast cancer in U.S. women
might be xenoestrogenic food dyes. We
examined the ability offood colorants to
stimulate ER-positive and negative cells to
enter the cell cycle. We also examined dye-
treated cells for effects indicating damage
to genetic material.
Materials and Methods
Chemicals
17P-Estradiol (E2) and ICI 182,780 were
gifts from J. Wimalasena ofthe University
ofTennessee Medical Center, Knoxville,
Tennessee. DDT (Sigma Chemical Co, St.
Louis, MO) and estradiol were made up as
concentrated solutions in abaolute ethanol.
An equal amount ofethanol was added to
all control cells. Red No. 3 (erythrosin
bluish CI 45430) (Pfaltz and Bauer,
Waterbury, CT) was dissolved in sterile,
distilled water. DNA-damaging chemicals
and chemotherapeutic agents (Sigma) were
used as previously described (16). All other
food colorants were obtained from Pfaltz
and Bauer, Aldrich Chemicals (Milwaukee,
WI), Kodak Fine Chemicals (Rochester,
NY), or local suppliers.
Cells
The ER-positive MCF-7 and HTB 133
human breast carcinoma cell lines were
gifts from J. Wimalasena ofthe University
ofTennessee Medical Center. HTB 125
ER-negative cells were obtained from
the American Type Culture Collection
(Rockville, MD). Breast cells were main-
tained in Dulbecco's modified minimal
essential medium (DMEM)/Hams F12 1:1
without phenol red. Both cell lines were
incubated at 37°C in a 5% CO2 atmos-
phere with 10% fetal bovine serum (FBS).
Prior to studies on cyclin-dependent kinase
2 (Cdk2) activation, MCF-7 cells were
growth arrested by removal ofserum and
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transfer into methionine-free medium for
72 hr before exposure. During xenoestro-
gen exposure, breast cells were maintained
in methionine-containing DMEM/F12
(phenol red and FBS free).
Rat liver epithelial (RLE) cells were a
kind gift from J. Trosko ofMichigan State
University, East Lansing, Michigan. RLE
cells, which are ER-negative (C Dees,
unpublished data), were maintained in
Richter's medium.
ProliferationAssays
Proliferation assays were performed by
placing the cells in serum-free phenol red
and methionine-free medium for 24 hr.
Before adding xenoestrogens, cells were
returned to media containing methionine
but without serum or phenol red. Cells
were incubated with xenoestrogens for
72 hr and then released by trypsinization.
Cell counts were performed manually or
with a Coulter model S cell counter.
Cdk2Asays
Cdk2 assays were performed as described
previously by Foster and Wimalasena (17).
Cells for Cdk2 analysis were exposed for
20 hr. After incubation, MCF-7 cells were
washed twice with ice-cold phosphate-
buffered saline (PBS) and lysed by the
addition ofcold lysis buffer (Tris 20 mM,
pH 7.5, NaCG 250 mM, NP-40, 0.1%
NaF 10 mM, NaVO 1 mM, phenyl-
methylsulfonyl fluoride [PMSF] 1 mM).
After 15 min on ice, the lysates were cen-
trifuged at 20,000xg for 15 min (40C).
Cdk2 was precipitated from equal amounts
of cell extracts using purified rabbit anti-
Cdk2 (Santa Cruz Biotechnology, Santa
Cruz, CA) and Protein A/G agarose.
Immunoprecipitates were washed (three
times) with lysis buffer and twice with
kinase buffer (Tris 40 mM, pH 7.5, MgC12
10 mM). The immunoprecipitates were
suspended in 30 pl ofkinase buffer supple-
mented with 400 pg/ml histones (Sigma
type II-SS [HH1]), 5 pM ATP, 0.5 pM
dithiothreitol, 0.5 mM EGTA, and 5 pCi Y-
[32P]-ATP for 20 min at room temperature.
The reaction was stopped using gel electro-
phoresis sample buffer, and the reaction
products were separated on a 14% poly-
acrylamide gel (Novex, San Diego, CA).
ER-EREMobiityShiftPrcedures
Cells were cultured in 175-cm2 flasks in
DMEM/F12 (phenol red free) supple-
mented with 10% FBS. The medium was
replaced with fresh medium without serum
24 to 48 hr prior to adding compounds for
growth promoting effects. Cells were then
incubated for 1 hr with xenoestrogens or
exposed to electromagnetic fields (EMF)
for 1 hr. Cell extracts were prepared by
removing the medium and washing the
monolayers three times with PBS, pH 7.4.
Cells were lysed by the addition ofbinding
buffer (20% glycerol, 0.4 mM KCI, 2 mM
DTT, 1 mM PMSF, in 20 mM Tris-HCl
buffer, pH 7.5) using a glass Dounce
homogenizer. The lysate was centrifuged at
10,000xgfor 15 min and the supernatants
retained for testing. Total protein content
ofthe extracts was determined using BCA
protein assays (Pierce Biochemicals,
Rockford, IL). Protein content for all sam-
ples was equalized prior to performing the
binding assay. The estrogen responsive ele-
ment (ERE) (GTCCAAAGTCAGGTCA
CAGTGACCGATCAAGTT) as described
by Kumar and Chambon (18) and the
complementary strand were synthesized,
prepared in double-stranded form, and
end-labeled with [32P]-ATP using T4
kinase. Binding reactions consisted of 5 pl
of protein (approximately 5 ng), 0.5 ng
32P-labeled oligonucleotide, 1 pl of a
1.9-pg/ml Poly dl, dC solution (Sigma
Chemical, St. Louis, MO), and 25 pl bind-
ing buffer. Binding reactions were incu-
bated at room temperature for 20 min.
The entire reaction mixture was then sepa-
rated on 6% nondenaturing polyacry-
lamide gels (Novex, San Diego, CA) and
visualized by autoradiography.
Competitive binding studies using the
ER from MCF-7 were performed as
described previously (11) with modifica-
tions to accommodate the use ofcultured
cells. To confirm visual interpretation of
ER-ERE mobility shift increases stimu-
lated by xenoestrogens, autoradiographs
were scanned using a Hewlett Packard
ScanJet IIcx. Densitometric evaluation was
performed using SigmaScan software.
p53MobilityShiftProcedures
Procedures for p53 mobility shift assays
were similar to those described previously
(16,19,20). RLE cells were cultured in
175 cm2 flasks in Richter's medium sup-
plemented with 0.5% newborn calfserum.
The medium was replaced prior to adding
compounds for testing with fresh medium
containing test compounds without serum.
Cells were then incubated for 2 hr with
DNA-damaging agents or exposed to
EMF. Untreated control cells were also
examined. S9 homogenate (Molecular
Toxicology, Annapolis, MD) was prepared
from rats treated with Aroclor 1254. The
S9 mix components were 8 mM MgCl2,
33 mM KCl, 5 mM glucose 6-phosphate,
4 mM NADP, 100 mM sodium phos-
phate, pH 7.4, and S9 at 10% (v/v) ofmix.
Food colorants were added to 1-ml S9 mix
and then added to cultured cells.
Nuclear extracts from the cells were
prepared as described (13). Briefly, the
medium was removed from the cells and
the monolayers washed with PBS, pH 7.4.
Cells were lysed by the addition of2.5 ml
buffer (20% glycerol, 10 mM NaCl, 1.5
mM MgCI2, 0.2 mM EDTA, 1 mM DTT,
1 mM PMSF, and 0.1% Triton X-100 in
20 mM HEPES buffer, pH 7.6). The
lysate was centrifuged at 800xgfor 4 min;
the resulting pellet was diluted with three
volumes of 500 mM NaCl in buffer (see
previous description), then incubated at
4°C for 30 min with agitation. The mix-
ture was centrifuged at 35,000xgfor 10
min and the supernatants containing p53
were removed for immediate analysis. The
total protein content of the extracts was
determined using BCA protein assays
(Pierce Biochemicals). Protein content for
all samples was equalized prior to perform-
ing the binding assay. The consensus p53
binding sequence (GGACATGCCCGGG
CATGTCC) was synthesized, prepared in
double-stranded form, and end-labeled
with [32P]-ATP). A 21mer randomized at
each base was synthesized and used as a
nonspecific competitor control. Binding
reactions consisted of20 pg nuclear pro-
tein, 0.5 ng 32P-labeled oligonucleotide,
and 0.5 pg salmon sperm DNA (Sigma
Chemical) with buffer (without Triton) in
a final volume of25 pl. Binding reactions
were incubated at room temperature for
20 min; 8 pl of the reaction mixture was
separated on 6% nondenaturing poly-
acrylamide gels (Novex) and visualized
byautoradiography.
Results
Cell Proliferation Studies
We examined a number ofsynthetic food
dyes to determine their potential for
growth-promoting activity on ER-positive
growth-arrested human breast cancer cells.
The effects ofRed No. 3 were also tested
on ER-negative HTB 125 breast cells and
on a RLE cell line. One synthetic food dye
(Food Drug and Cosmetics Red No. 3)
was found to stimulate the growth of ER-
positive human breast cancer cells in pro-
portion to the applied dose (Figure IA).
ER-negative cultured breast cells did not
respond to Red No. 3 (Figure 1B), nor did
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RLE cells (Figure 1C). However, HTB 125
cells may be myoepithelial in origin,
whereas HTB 133 cells are transformed and
are probably derived from secretory epithe-
lia. Therefore, HTB 125 cells may differ
from HTB 133 cells in many other aspects
besides being ER-negative. ER-positive
breast cancer cells also respond to DDT in
a dose dependent manner (Figure 2A),
whereas RLE did not respond (Figure 2B).
These two studies suggest that Red No. 3
could stimulate the growth of human
breast cells and that effects are mediated
through the ER. Therefore, we examined
the effects ofthe steroidal antiestrogen ICI
182,780 on breast cells treated with Red
No. 3, DDT, andO-estradiol. Antiestrogen
treatment (10 nM) suppressed the prolifer-
ation of breast cells stimulated by DDT
(0.3 pM) and Red No. 3 (10 jig/ml)
but not f-estradiol (10 nM) (Figure 2C).
Higher concentrations of ICI 182,780
(150 nM) suppressed the effects of1-estra-
diol (Figure 2C). These lines ofevidence
suggest that Red No. 3 is a xenoestrogen
similar to phenol red and DDT.
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Figure 1. Red No. 3 induces a dose dependent stimu-
lation of the growth of ER-positive HTB 133 cells (A).
Red No. 3 does not stimulate growth in ER-negative
human breast cells (B) or in RLE cells (C). Tops of bars
indicate the mean of three replicate counts. Error bars
represent the standard deviation. Treatment groups
were analyzed using analysis ofvariance followed by a
Student's t-test modified to account for pooled vari-
ance. Treatment groups with the same number of
asterisks are not significantly different from each other
where n=3, a=0.05.
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Figure 2. DDT increases the growth ofER-positive HTB
133 cells (A) but ER RLE cells were unaffected (B). DDT
and Red No. 3 enhance the growth of HTB 133 cells;
the effects of Red No. 3 (10 pg/ml) are significantly
less than stimulated by DDT, and DDT(0.3 pM) effects
are less than that of estradiol (10 nM). Treatment of
HTB 133 cells with the steroidal antiestrogen ICI
182,780 (10 nM) suppresses DDT and Red No. 3 but
not estradiol. Suppression of estradiol-induced cell
growth required approximately 15 times more ICI
182,780(150 nM).
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Competitive Bindingand
ERMobilityShiftStudies
Competitive binding studies (11) were used
to confirm that Red No. 3 has estrogenic
activity. Red No. 3 successfullycompeted for
the ER from the MCF-7 cells (Figure 3).
Red No. 3 (25 pg/ml) increased ER-ERE
binding approximately 2.5-fold over that
produced by the control (1 times protein
control). Doubling the protein in the control
reaction mixture (2 times protein control)
increased the intensity ofthe ER-ERE com-
plex approximately 3-fold higher than pro-
duced by the 1 times protein control (Figure
4A). The lowest concentration ofestradiol
that increased ER-ERE binding was 100
pM, which increased ER-ERE intensities
approximately 1.3-fold over the 1 times pro-
tein control. DDT (300 nM) increased
ER-ERE binding nearly 2-fold over the
1 times protein control (Figure4A).
Red No. 3 increased ER-ERE binding
1.5-fold over the protein control (Figure
4B). Low concentrations of ICI 182,780
(10 nM), when added to the medium of
HTB 133 cells containing Red No. 3 (25
pg/ml), completely inhibited increased ER
binding to the ERE but only partially
inhibited the response stimulated by DDT
(0.3 pM) (0.5-fold of the control) and
P-estradiol (10 nM) (0.5-fold of the con-
trol) (Figure 4B). Complete inhibition of
estradiol-induced ER-ERE binding by ICI
182,780 requires 10 to 15 M excess ofthe
inhibitor (17). ICI 182,780, when used at
a concentration 10 to 15 times that of
estradiol, can inhibit the ER-ERE binding
to levels below that ofthe untreated con-
trols (17). Since ICI 182,780 can inhibit
Red No. 3 ER-ERE complex formation
(Figure 4B) and stimulation ofcell growth
(Figure 2), this confirms that the actions of
Red No. 3 are mediated through the ER.
Figure 4B shows that phenol red (50
pg/ml) simulates the ER-ERE binding as
well (1.3-fold increase over control).
'0 A OEstradiol
10 ARed3 10\
0o
1 0-1 0 10 10
Cold competitor, M
Figure 3. Red No. 3 and DDT compete successfully for
the MCF-7 cell ER in competitive binding assays.
Affinityforthe ER by Red No. 3 and DDT is significantly
less than that of estradiol.
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Figure 4. (A) DDT (0.3 pM) and Red No. 3 (25 pg/ml) stimulate the binding of the ER to the ERE using gel mobility
shift assays on extracts from treated HTB 133 cells. Estradiol (100 pM) stimulated ER-ERE binding but to a lesser
extent when compared to untreated control cells. No effect was seen when 50 pg/ml of Blue No. 1, Green No. 3,
Red No. 40, orYellow No. 5 were added to ER-positive cells (not shown). (B) The addition of ICI 182,780 (150 nM)
and Red No. 3 completely prevented ER-ERE binding in Red No. 3-treated MCF-7 cells. ICI 182,780 partially pre-
vented ER-ERE binding in cells treated with estradiol or DDT. Note that another xenoestrogen, phenol red,
enhances ER-ERE binding.
Cycfin KinaseAssays
Entrance into the cell cycle requires aciva-
tion ofCdk2, which is a late event in G1/S
transition (21,22). The cyclin E-Cdk2
complex then phosphorylates the tumor
suppressor protein pRb1O5 (21-23). We
reasoned that ifRed No. 3 were capable of
stimulating breast cell growth, the activity
ofCdk2 must be increased in treated cells.
Increased activity of Cdk2 can be demon-
strated in ER-positive breast cancer cells
using immune complex assays with histone
H I as the target (Figure 5) (17). DDT
stimulates Cdk2-associated kinase activity
in MCF-7 breast cancer cells, but increased
Cdk2 activity requires larger amounts of
DDT when compared with estradiol
(Figure 5A). Increased Cdk2 activity was
also stimulated by adding Red No. 3
to MCF-7 cells (Figure 5B). Between 3 to
10 pg/ml of Red No. 3 were required to
achieve the same phosphorylation of the
histone target as that produced by 2% (v/v)
FBS (Figure 5B). The activation of Cdk2
by Red No. 3 and DDT confirms that these
compounds can stimulate human breast
cancer cells to enter the cell cycle. Prelimi-
nary studies using Red No. 40 on MCF-7
cells have failed to show any stimulation of
Cdk2 activity (data not shown).
Efes on p53-DNA Binding
The current paradigm for cancer etiology
suggests that two major effects are required
for cells to become cancerous: irreversible
genetic damage and promotion ofcell divi-
sion. Our studies suggest that Red No. 3 is
a xenoestrogen capable ofstimulating the
proliferation ofcultured breast cells. To be
a complete carcinogen, Red No. 3 must
also be capable ofdamaging genetic mater-
ial. We examined the effects ofRed No. 3,
Blue No. 1, Green No. 3, and Yellow No.
5 for potential effects on p53-DNA
sequence-specific binding in RLE cells and
the human breast cell lines HTB 125 (ER-
negative, normal human breast, myoep-
ithelial), MCF-7 (ER-positive, human
ductal carcinoma) and HTB 133 (HTB
133, ER-positive human ductal carci-
noma). DDT and DNA-damaging agents
including actinomycin, mitomycin C, and
5-fluorouracil (5-FU), also were tested for
effects on p53-DNAsite-specific binding.
Figure 6 shows that p53 extracts
prepared for DNA binding studies, which
were isolated from MCF-7 cells treated
with Red No. 3 (100 pg/ml), are intensely
red colored. Cells treated with other food
colorants do not show any indication of
colorant association with the exception of
Green No. 3. Extracts from MCF-7 cells
treated with Green No. 3 are very slightly
colored (Figure 6). Therefore, Red No. 3
appears to penetrate human breast cancer
cells in vitro and has access to the nuclear
compartment including the genetic material
and the enzymes that modify it.
After the treatments, p53-DNA site-
specific binding increased in cultured HTB
125 breast cells after the application of
DNA-damaging chemotherapeutic agents
and Red No. 3 (Figure 7A). Titration of
Red No. 3 on RLE cells showed that treat-
ment of the cells for 2 hr with 25 pg/ml
was sufficient to increase p53-DNA bind-
ing. As little as 100 ng/ml of Red No. 3
was sufficient to significantly increase p53
binding after a 4-hr exposure (data not
shown). For unknown reasons, DDT failed
to increase p53-DNA binding when added
to the medium ofRLE cells (Figure 7A).
We also examined other commonly
used food dyes to determine their effects
on p53-DNA binding and if metabolic
activation or inactivation might occur by
treatment with S9 liver extract. Blue No. 1,
Green No. 3, and Yellow No. 5 slightly
increased p53 binding in MCF-7 cells after
treatment with S9 but not without treat-
ment (Figure 7B). Red No. 3 stimulated
the largest increase in p53-DNA binding
without S9 treatment (Figure 7B). Although
S9 treatment of Red No. 3 had no addi-
tional effect, p53-DNA site-specific bind-
ing was increased in HTB 133 cells treated
with Red No. 3. The effects of Red No. 3
and other dyes on HTB 133 cells were sim-
ilar to our studies using MCF-7 cells
(Figures 7B, 7C). Preliminary studies using
Red No. 40 on MCF-7 cells have shown no
effect on p53-DNA binding (not shown).
Some nongenotoxic stresses increase
p53-DNA binding, including hypoxia and
heat shock (24,25). The increases in
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Figure 5. (A) DDT and estradiol increase the phosphorylation of histone Hl (HH1) by Cdk2 immur
from treated MCF-7 cells. (B) Red No. 3 also stimulates the activity of Cdk2 when added to starve(
Approximately 3 to 10 pg/ml of Red No. 3 are required to detect increased phosphorylation of the t
which is approximately equal to that stimulated bythe addition of 2% (v/v) FBS.
Figure 6. MCF-7 cell extracts that have been prepared for p53-DNA binding studies from cells tre;
No. 3 (100 pg/mI) are strongly colored. Little or no color is associated with extracts treated with o0
including Red No. 40.
p53-DNA binding stimulated in RLE and
human breast cells may occur by some
mechanism other than DNA damage.
However, it has been demonstrated that
p53 recognizes damaged DNA (25,26)
and it has not been reported that treatment
of cultured cells with nongenotoxic agents
such as estrogen will stimulate p53-DNA
binding. Preliminary studies suggest that
treatment ofDNA with Red No
modification of the DNA using
endonucleases alters the results
by action of the endonuclease
unpublished data). Preliminary,,
suggest that Red No. 3 decreases
in the Ames II test (C Dees, u
results). These results are cons
two previous studies that suggest
interacts directly with DNA or affects
DNA-modifying enzymes (genointeractive)
(28,29). Few other studies have examined
the risks of DNA damage that might be
associated with food colorants. No studies
have specifically investigated the effects of
synthetic food colorants on human breast
cells. Red No. 3 has been shown to be
mutagenic in the Bacillus subtilus sporula-
tion assay (28), genointeractive in the
Salmonella typhimurium assay (Ames test)
(29), and carcinogenic in B6C3F1 mice
(increased pheochromocytomas in males)
(30). In the B. subtilus sporulation assay,
S9 treatment appeared to decrease the
effect of Red No. 3 (28), whereas in our
study S9 treatment appears to have no
effect. We believe that our results using a
p53-gel mobility shift assay are consistent
with a conclusion that Red No. 3 is capable
HH1 ofdamaging DNA.
Discussion
noprecipitated Estrogen increases the risk ofbreast cancer
d MCF-7 cells. (31), but the importance ofxenoestrogens
histone target, such as DDT in the etiology of breast
cancer remains controversial (7,12-14). It
is interesting to note that the major route
ofexposure to a number ofxenoestrogens
is through the food chain (32). However,
while the incidence ofbreast cancer in the
United States is increasing, exposure levels to
several estrogenic pesticides and pollutants
are decreasing (32).
In contrast, the diet ofwomen in the
United States includes processed foods that
are increasingly likely to contain food col-
orants and additives (27). Industrialized
countries rely heavily on processed foods;
over the last several decades about 80% of
their food supply has been processed by the
food industry (27,33). Further, the use of
food additives continues to increase at a
rate of4 to 5% annually (34). Processed
foods are also more likely to be packaged in
materials that may contaminate the food
with estrogenic plasticizers (15). Therefore,
ated with Red as the diet of industrialized countries
ther colorants, becomes more reliant on processed foods,
the exposure to estrogenic dyes, preserva-
tives, and contaminants from packaging
materials increases. Estrogenic pesticides
3 prior to and pollutants also contribute to the total
restriction xenoestrogen exposure via foods.
s produced It is difficult to determine the total
s (C Dees, dietary consumption ofsynthetic colorants
studies also and only a few studies have examined this
s mutations issue. As documented by the National
npublished Academy of Sciences/National Research
istent with Council (NAS/NRC) in 1979, the reported
Red No. 3 consumption of all food colorants by
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Figure 7. (A) Two hr after Red No. 3 (25 pg/ml) is added to HTB 125 human breast cells, increased levels of p53
can be detected using a gel mobility shift assay. DNA-damaging and chemotherapeutic agents also increase p53
levels in these cells. (B) Red Dye No. 3 increases the p53 levels 2 hr after treatment of MCF-7 cells. Simultaneous
addition of S9 rat liver extract failed to affect p53 levels in these breast cancer cells. Minor changes in p53 levels
could be detected when other dyes were tested, but p53 levels in MCF-7 cells were the most dramatically
increased. (C) The effects of Red No. 3 on HTB 133 human breast cells were similar to those noted when HTB 125,
MCF-7, or RLE cells were tested.
people over the age of 2 years in the
United States during 1977 averaged
70 mg/kg/day. The top 1% of this group
consumed 239 mg/kg/day of all food col-
orants and 1 mg/kg/day of Red No. 3
(35). With the use of food colorants
increasing at a rate of 4 to 5% each year
since the time ofthe original survey (34),
the amount ofRed No. 3 being consumed
by the top 1% in 1995 would be estimated
at 2.508 mg/kg/day using +5% each year
(2.025 mg/kg/day at +4% each year).
Assuming an equal distribution in body
water, the highest estimate would represent
a daily dose ofRed No. 3 that is approxi-
mately 30 times greater than the concen-
tration of Red No. 3 required to induce
p53 in cultured cells after a 4-hr exposure
(100 ng/ml). The NAS/NRC reported that
the intake at the 50th percentile was 11%,
and the 90th percentile was 41%, of that
reported for the top 1% (35). Thus halfof
the population may consume sufficient
Red No. 3 to produce a tissue concentra-
tion approximately 3 times greater than
that necessary to cause genetic damage to
human cells in culture, and 10% of the
population consumes approximately 12
times more. Even ifthere is a 5-fold overes-
timation in the consumption ofRed No. 3,
the daily intake ofRed No. 3 would still be
6 times greater than that required to pro-
duce risk-enhancing effects in vitro for the
top 1% and approximately 2 times greater
for the top 10%. Perhaps more important,
the reported intake from young childhood
through puberty was actually higher than
for the total population: approximately 1.6
to 2.5 mg/kg/day at the 90th percentile
(adjusted to 1995 estimates as above).
Thus, during growth and development the
intake ofRed No. 3 may actually be higher
than that necessary to induce p53 binding
for greater than 10% ofthe population at a
time when developing breast tissues may be
most susceptible to xenobiotic challenge.
In addition to inducing p53 binding to
DNA, Red No. 3 also causes an induction
of cell proliferation (inhibitable by anti-
estrogen) at a concentration of 10 pg/ml.
This concentration is only approximately 3
times greater than the predicted concentra-
tion for the top 1% ofthe population or
the top 10% ofyoung children consuming
dye-containing foods. The predicted physi-
ological concentration of Red No. 3 is
approximately 33% ofthe level necessary
to enhance cell proliferation in vitro.
However, it should be noted that the full
interaction of growth factors on signal
transduction in relation to steroid binding
to ER, and the role ofgrowth factors in
inducing ER-positive cells to enter and
complete the cell cycle, remains to be fully
elucidated. For example, the ability of
xenoestrogens to induce breast cancer cells
to enter the cell cycle is enhanced when
other growth factors (e.g., insulin) are pre-
sent (36). Growth factors such as insulin,
insulinlike growth factor, and epidermal
growth factor are able to phosphorylate
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and activate the ER via kinase activated
signaling pathways without the presence of
compounds bound to the ER ligand bind-
ing site (37,38). Phorbol esters are also able
to induce the phosphorylation of the ER
(39). When the ER is phosphorylated it
can bind to the estrogen responsive ele-
ments without a compound bound to the
ligand binding site (38). In addition, other
investigators have documented that the
activity ofone xenoestrogen may be syner-
gistically enhanced when another one is
present (40). Other factors may greatly
enhance the ability ofxenoestrogens such as
Red No. 3 to induce ER-positive cells to
enter the cell cycle. Therefore, a concentra-
tion of Red No. 3 in vivo that is 33% of
that necessary to cause proliferation in vitro
maybe sufficient to trigger ER-positive cells
to progress to the cell cycle.
Cancer risk from Red No. 3 may be
further increased ifdeveloping reproduc-
tive tissues are exposed. The effects ofextra
estrogen on developing reproductive tissue
has been demonstrated. In laboratory ani-
mals the mammary glands offemale mouse
pups exposed to inappropriate levels of
estrogen during development are larger
than those of control animals (41,42).
Furthermore, the increase in terminal end
bud formation observed in these mice
increases the likelihood that they will
develop breast cancer (41,42). In addition,
exposure to estrogens during the develop-
ment ofthe mouse reproductive tract per-
manently estrogenizes cells (43). Two
genes that respond to estrogen (lactoferrin
and epidermal growth factor) are persis-
tently expressed after exposure to estrogen
during development (43). Thus, the great-
est risk associated with exposure to xeno-
estrogens may occur during the period
from early childhood through puberty, a
period in which the highest consumption
ofRed No. 3 occurs.
While the role of diet in increasing
breast cancer risk ofU.S. women is gener-
ally accepted, the particular component of
the diet that confers the risk is not. Most of
the current studies on the factors in the
diet of U.S. women that contribute to
breast cancer have focused on total fat con-
tent. Processed foods contain the highest
levels ofadded fat also and are foods most
likely to contain the highest levels offood
colorants. Therefore, it is possible that the
correlation ofhigh fat foods to increased
risk of breast cancer noted in previous
studies is actually caused by the presence of
xenoestrogenic food additives such as Red
No. 3. Xenoestrogenic food additives and
other xenoestrogens that are found in
foods, including pollutants (e.g., dioxins,
polychlorinated biphenyls), packaging cont-
aminants (phthalates), and pesticides, may
be in total the dietary factor that con-
tributes to the high breast cancer risk of
women in the United States and other
industrialized countries. However, many
other factors are likely to increase the risk of
breast cancer for women living in industri-
alized countries. Additional risk factors may
include high fat diets, poor exercise habits,
and high total body fat (6). The age of
menarche or menopause, alcohol use, and
parity may also increase risk. While our
studies suggest that a xenoestrogenic food
dye may increase the risk ofbreast cancer,
further studies are required to determine if
the estrogenic and genotoxic effects ofRed
No. 3 on cells in vitroalso occur in vivo.
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